Abstracts

Modeling Functional Cure of HIV in Nonhuman Primates Using Gene-Modified Hematopoietic Stem Cells

Background: Following hematopoietic stem cell (HSC) transplantation and withdrawal of combination antiretroviral therapy (cART), three previously HIV+patients remain free of measurable replication-competent virus. These results suggest that HSC transplantation represents a promising strategy to induce a functional cure. To better understand the mechanism of HSC-driven HIV control, and apply this therapy to a greater number…

Comparative Effectiveness of HIV Care and Treatment Programs in East Africa

Background: Survival after initiation of antiretroviral treatment (ART) among HIV-infected patients in Africa is a critical measure of the effectiveness of the public health response. Regional differences in mortality, after adjustment for biological factors (e.g., pre-therapy CD4 value), would suggest that the behavior of health care systems and patient populations play an important role in…

HIV Care Cascade Among Hard to Reach Populations in India: Need to Expand HIV Counseling and Testing

Background: Early identification of HIV infection, prompt linkage to care, retention, initiation of ART and suppression of viral load (VL) are critical steps along the HIV care cascade. Hard-to-reach groups such as injection drug users (IDUs) and men who have sex with men (MSM) lag behind at each step, particularly in low-and-middle-income settings where access…

Unplanned Interruptions in HIV Care in Nigeria: Rates and Implications

Background: Unplanned care interruptions pose a challenge to effective HIV treatment. However, little is understood about rates of interruptions and how to minimize interruptions in care in resource-limited settings. Our objective was to determine the frequency, risk factors, and impact of unplanned care interruption on virologic outcomes among HIV-infected patients in Nigeria. Methodology: We conducted…

Is Latent TB Infection Really Latent?

Background: Global tuberculosis (TB) eradication efforts are hampered by the vast reservoir of persons with latent TB infection (LTBI). Although the lifetime risk of reactivation is 5-10% among immune competent persons, HIV-infected persons have a ~10% annual risk of reactivation. For this reason, it is recommended that those with HIV infection are tested for LTBI…

Quantifying TB Treatment Response Using PET/CT

Background: Definitive clinical trials of new chemotherapy for tuberculosis (TB) treatment require following subjects until at least six months after they discontinue taking medicine to assess durable cure, making these trials expensive and lengthy. Surrogate endpoints relating to treatment failure and relapse are currently limited to sputum microbiology, which is neither very sensitive nor very…

Population-Level Control of HIV-Related TB

Background: TB is still among the most common causes of death of people living with HIV (PLWH). TB remains out of control in Southern Africa where rates can be more than 1000/100,000 population per year (compared to less than 10 in some high income countries). Conclusions: To control HIV-related TB we need social, structural and…